Schedule 13G ownership disclosure

X4 Pharmaceuticals Inc

Common Stock · CUSIP: 98420X202

Event date: 2025-06-30

Filing-level shares
179,125.00
Percent of class
3.0%
  • BlackRock, Inc.

    Shares: 179,125.00 · Class: 3.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-003306
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Jul 18, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub